corneal endothelial cell therapy (Astellas)

N/A

Report date: 2025/03/18 18:23:50

Base Information

Drug Namecorneal endothelial cell therapy (Astellas)

Drug Alias Namecorneal endothelial cell therapy (Advanced Cell Technology)corneal endothelial cell therapy (Ocata)human embryonic stem cell derived corneal endothelial cells (Ocata)

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Embryonic stem cells therapy

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsCorneal DiseasesBlindness

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAstellas Institute For Regenerative Medicine

China Registration ClassN/A

Develop Information

Active CompaniesAstellas Pharma Inc

Inactive CompaniesAstellas Institute For Regenerative Medicine

Active IndicationsCorneal DiseasesBlindness

Inactive IndicationsN/A

Other Information

ATC CodeN/A